… body’s rapid tailspin towards insulin resistance again. It motivated by a desire to help others take control of their health, their bodies, their state of mind and their success. The Fat Burn Detox Factor is a weight-loss Program that is acquiring …
Category: Inflammation
Research may show new ways to repress inflammation at outset
Researchers at the University of Tubingen, working with colleagues in other parts of Germany and in the United States, have identified an enzyme as a kind of biological gauge regulating inflammation in the human body. Professor Alexander Weber of the Interfaculty Institute of Cell Biology says the enzyme – Bruton’s tyrosine kinase or BTK – is switched on when an inflammation occurs in the body, playing a key role in the inflammation’s subsequent development.
10 Proven Health Benefits of Cherries You Need to Know
Cherries are especially useful for treating gout. Gout is a kind of arthritis linked to an unusually high amount of uric acid in the bloodstream.
Four mistakes people make when going gluten-free
… they are shopping with one rule: “Buy gluten-free.” Avoiding gluten is not necessarily a guarantee of improved health! Gluten is what makes food have great texture, bounce and fluffiness. Have you tasted some of the gluten-free breads out there? Not …
AnaptysBio Up Slightly In IPO
San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M in its IPO, and closed up slightly in its first day of trading on Thursday. Anaptys priced its IPO on Wednesday night at $15.00 per share, at the midpoint of its $14.00 to $16.00 estimated IPO range, and closed the day at $17.00 per share.
AnaptysBio Sets Estimated IPO Pricing Range
San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 per share. The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB.
Ticagrelor induced systemic inflammatory response syndrome
Ticagrelor is a reversible and direct-acting oral antagonist of the adenosine diphosphate receptor P2Y12. Possible adenosine-mediated effects of ticagrelor on inflammation are complex and incompletely understood.
DRGT’s novel Celecoxib composition – opportunity for low dose,…
DRGT, a specialty pharmaceutical company announced today the Phase I clinical results of its DRGT-46 and DRGT-47 programs, new compositions of Celecoxib – a COX-2 selective nonsteroidal anti-inflammatory drug . There are many treatment options for pain.
Long-term anti-inflammatory drug use may increase cancer-related deaths for certain patients
… Felix, PhD, co-lead author of the study and cancer epidemiologist with the OSUCCC – James and College of Public Health. “These results are intriguing and worthy of further investigation,” says David Cohn, MD, gynecologic oncology division director …